ReviewBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2025
Salvia miltiorrhiza: insights on the protective effect and mechanism of myocardial ischemia-reperfusion injury.
Review in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on the molecular mechanisms of tanshinone IIA in the treatment of cardiovascular and cerebrovascular diseases (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial ischemia-reperfusion injury (MIRI), a common secondary complication of cardiovascular diseases (CVDs), leads to significant psychological and physiological distress in patients. Pathophysiological reactions including inflammatory response, oxidative stress injury, platelet aggregation, vascular endothelial dysfunction, and programmed cell death are involved in the pathogenesis of MIRI. Prolonged use of conventional therapies (e.g., NSAIDs, calcium channel blockers, beta-blockers, and antiplatelet agents) may exacerbate cardiovascular damage due to adverse effects. Thus, identifying complementary and alternative therapies with better efficacy and safety profile is imperative. Unlike single-target pharmacological approaches, Salvia miltiorrhiza Bunge exhibits pleiotropic effects by modulating multiple pathways, including inflammation, oxidative stress, and vascular function. This review summarizes the protective mechanisms of Salvia miltiorrhiza against MIRI, highlighting its potential as a translational therapy for MIRI and guiding future preclinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.